EpiVario Secures Exclusive Worldwide License for Novel Technologies and Drugs for Memory-Related Psychiatric Diseases from University of Pennsylvania.

Press/Media

Period16 Jan 2019

Media coverage

1

Media coverage

  • TitleEpiVario Secures Exclusive Worldwide License for Novel Technologies and Drugs for Memory-Related Psychiatric Diseases from University of Pennsylvania.
    Media name/outletPRWeb Newswire
    Country/TerritoryUnited States
    Date16/01/19
    PersonsPhilipp Mews
View all 1
View less